748 related articles for article (PubMed ID: 24508696)
21. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
[TBL] [Abstract][Full Text] [Related]
22. Uveal melanoma.
Kashyap S; Meel R; Singh L; Singh M
Semin Diagn Pathol; 2016 May; 33(3):141-7. PubMed ID: 26972224
[TBL] [Abstract][Full Text] [Related]
23. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
[TBL] [Abstract][Full Text] [Related]
25. Pathology and genetics of uveal melanoma.
Griewank KG; Murali R
Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
[TBL] [Abstract][Full Text] [Related]
26. The genetic basis of uveal melanoma.
Nielsen M; Dogrusöz M; Bleeker JC; Kroes WG; van Asperen CA; Marinkovic M; Luyten GP; Jager MJ
J Fr Ophtalmol; 2015 Jun; 38(6):516-21. PubMed ID: 25976137
[TBL] [Abstract][Full Text] [Related]
27. Update on uveal melanoma: Translational research from biology to clinical practice (Review).
Ortega MA; Fraile-Martínez O; García-Honduvilla N; Coca S; Álvarez-Mon M; Buján J; Teus MA
Int J Oncol; 2020 Dec; 57(6):1262-1279. PubMed ID: 33173970
[TBL] [Abstract][Full Text] [Related]
28. Uveal melanoma: physiopathology and new in situ-specific therapies.
Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
[TBL] [Abstract][Full Text] [Related]
29. [What else can we do for uveal melanoma].
Li B; Xu XL
Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
[TBL] [Abstract][Full Text] [Related]
30. Ocular melanoma.
Grin-Jorgensen C; Berke A; Grin M
Dermatol Clin; 1992 Oct; 10(4):663-8. PubMed ID: 1395150
[TBL] [Abstract][Full Text] [Related]
31. Clinical Management of Uveal and Conjunctival Melanoma.
Blum ES; Yang J; Komatsubara KM; Carvajal RD
Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
[TBL] [Abstract][Full Text] [Related]
32. Uveal melanoma: relatively rare but deadly cancer.
Kaliki S; Shields CL
Eye (Lond); 2017 Feb; 31(2):241-257. PubMed ID: 27911450
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
34. Update on Metastatic Uveal Melanoma: Progress and Challenges.
Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
[TBL] [Abstract][Full Text] [Related]
35. Uveal melanoma: Current evidence on prognosis, treatment and potential developments.
Gelmi MC; Jager MJ
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100060. PubMed ID: 38641203
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice.
Tolleson WH; Doss JC; Latendresse J; Warbritton AR; Melchior WB; Chin L; Dubielzig RR; Albert DM
Arch Ophthalmol; 2005 Aug; 123(8):1088-94. PubMed ID: 16087843
[TBL] [Abstract][Full Text] [Related]
37. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
38. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
Pardo M; García A; Thomas B; Piñeiro A; Akoulitchev A; Dwek RA; Zitzmann N
Proteomics; 2005 Dec; 5(18):4980-93. PubMed ID: 16267820
[TBL] [Abstract][Full Text] [Related]
39. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
[TBL] [Abstract][Full Text] [Related]
40. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]